Mr. Coutts is a Managing Director in the Liability Management practice within Houlihan Lokey’s Financial Restructuring Group. Over his nearly two decades with the firm, he has advised companies and creditors in restructurings, liability management transactions, M&A, financing, and valuation. He is based in the firm’s Los Angeles office.
Mr. Coutts’ featured notable transactions include:
Healthcare and Pharma: 21st Century Oncology, Accelerate Diagnostics, Alliance HealthCare Services, Angiotech Pharmaceuticals, Bausch Health, Better Health Group, Concordia Healthcare, Corizon Health, Covis Pharma, Elements Behavioral Health, Endo International, GenesisCare, KV Pharmaceutical Co., Lannett Co., LifeCare, M*Modal, Mallinckrodt Pharmaceuticals, Millennium Health, MultiPlan Corporation, NanoString Technology, P&L Development, Physiotherapy Associates, Purdue Pharma, Rural/Metro Corporation, Synergy Pharmaceuticals, and Wellpath.
Other Industries: Breitburn Energy Partners, Chemtura Corporation, Erickson Air-Crane, Frontier Airlines, Global Aviation, Molycorp, Reichhold Industries, SandRidge Energy, The Brock Group, THQ, Tradeshift, and Windsor Petroleum Transport Corporation.
Prior to joining Houlihan Lokey, Mr. Coutts was an auditor at Ernst & Young in Palo Alto, California.
Mr. Coutts graduated with highest honors from the Haas School of Business at the University of California, Berkeley, with a B.S. in Business Administration and holds an MBA from Northwestern University’s Kellogg School of Management. He is a Certified Public Accountant in the state of California.